Výsledky vyhľadávania - "Endometrial Neoplasms/pathology [MeSH]"

Laparoscopic surgery for endometrial cancer is oncologically safe and improves hospital stay duration: a retrospective single-center study over a 16-year period

Autori: Anna-Christina Rambow Moritz Nikolai Peer Jansen a ďalší

Zdroj: Arch Gynecol Obstet

Predmety: Adult, Aged, 80 and over, Length of Stay/statistics, Aged, 80 and over [MeSH], Aged [MeSH], Endometrial cancer, Endometrial Neoplasms/mortality [MeSH], Hysterectomy/statistics, Germany/epidemiology [MeSH], Neoplasm Staging [MeSH], Lymph Node Excision/statistics, Female [MeSH], Lymphonodectomy, Endometrial Neoplasms/surgery [MeSH], Laparoscopy/adverse effects [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Overall survival, Retrospective Studies [MeSH], Middle Aged [MeSH], Laparoscopy/statistics, Endometrial Neoplasms/pathology [MeSH], Total laparoscopic hysterectomy, Hysterectomy/methods [MeSH], Gynecologic Oncology, Total abdominal hysterectomy, Middle Aged, Length of Stay, Hysterectomy, Endometrial Neoplasms, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Germany, Humans, Lymph Node Excision, Female, Laparoscopy, Retrospective Studies, Aged, Neoplasm Staging

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38789852
https://repository.publisso.de/resource/frl:6496763

Peritoneal mesometrial resection with lymphadenectomy following prior hysterectomy in intermediate/high-risk endometrial cancer: feasibility and safety

Autori: Paul Buderath Mohamed Elgharib Rainer Kimmig

Zdroj: Arch Gynecol Obstet

Predmety: Female [MeSH], Endometrial Neoplasms/surgery [MeSH], Hysterectomy [MeSH], Humans [MeSH], Radiotherapy, Adjuvant/adverse effects [MeSH], Endometrial cancer, Neoplasm Recurrence, Local/pathology [MeSH], Feasibility Studies [MeSH], Neoplasm Staging [MeSH], Endometrial Neoplasms/pathology [MeSH], Endometrial Neoplasms/radiotherapy [MeSH], Sentinel node detection, Peritoneal mesometrial resection, Cancer field surgery, Lymph Node Excision/adverse effects [MeSH], Gynecologic Oncology, Targeted compartmental lymphadenectomy, Medizin, Humans, Feasibility Studies, Lymph Node Excision, Female, Radiotherapy, Adjuvant, Neoplasm Recurrence, Local, Hysterectomy, Neoplasm Staging, Endometrial Neoplasms, 3. Good health

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38217762
https://repository.publisso.de/resource/frl:6496612

Proteomics of Ishikawa endometrial cancer cells: impact of liposomal backbone

Autori: Shabnam Fayezi Amina Jasarevic Thomas Strowitzki a ďalší

Zdroj: BMC Res Notes
BMC Research Notes, Vol 17, Iss 1, Pp 1-4 (2024)

Predmety: Proteomics, Science (General), Proteome, QH301-705.5, Phosphatidylethanolamines, Data Note, Endometrial cells, Endometrial Neoplasms, Phosphatidylcholine, Q1-390, Cell Line, Tumor, Liposomes, Phosphatidylcholines, Medicine, Humans, Female, LC-MS/MS, Biology (General), Female [MeSH], Proteomics/methods [MeSH], Cell Line, Tumor [MeSH], Endometrial Neoplasms/metabolism [MeSH], Data Notes, Humans [MeSH], Phosphatidylethanolamines/metabolism [MeSH], Phosphatidylcholines/metabolism [MeSH], Endometrial Neoplasms/pathology [MeSH], Proteome/metabolism [MeSH], Liposomes [MeSH]

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39223611
https://doaj.org/article/462b7a6a0dcd48cfbb500054b84aaf2c
https://repository.publisso.de/resource/frl:6517969

Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach

Autori: Mustea, Alexander Ralser, Damian J. Egger, Eva K. a ďalší

Zdroj: J Cancer Res Clin Oncol

Predmety: Aged, 80 and over, Adult, 0301 basic medicine, TCGA, Female [MeSH], Molecular subtypes, Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Next generation-sequencing diagnostics, Humans [MeSH], Endometrial cancer, Middle Aged [MeSH], Endometrial Neoplasms/classification [MeSH], Exome Sequencing/methods [MeSH], Molecular surrogate markers, Endometrial Neoplasms/pathology [MeSH], Endometrial Neoplasms/genetics [MeSH], Research, Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], Middle Aged, Prognosis, Endometrial Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Exome Sequencing, Biomarkers, Tumor, Humans, Female, Aged

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39052171
https://repository.publisso.de/resource/frl:6499877

Treatment of endometrial cancer from 2000 to 2020 in Germany: a retrospective population based cohort study

Autori: Papathemelis, Thomas Ortmann, Olaf Kohl, Cynthia a ďalší

Zdroj: J Cancer Res Clin Oncol

Predmety: Aged, 80 and over, Adult, ddc:610, Research, 610 Medizin, Overall survival · Outcome · Multimodal therapy · Surgery · Radiotherapy · Chemotherapy · Retrospective cohort study, Middle Aged, Prognosis, Combined Modality Therapy, Female [MeSH], Outcome, Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Overall survival, Multimodal therapy, Retrospective Studies [MeSH], Middle Aged [MeSH], Endometrial Neoplasms/mortality [MeSH], Retrospective cohort study, Germany/epidemiology [MeSH], Survival Rate [MeSH], Endometrial Neoplasms/pathology [MeSH], Endometrial Neoplasms/epidemiology [MeSH], Prognosis [MeSH], Endometrial Neoplasms/therapy [MeSH], Chemotherapy, Combined Modality Therapy [MeSH], Surgery, Radiotherapy, Registries [MeSH], Endometrial Neoplasms, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Germany, Humans, Female, Registries, Retrospective Studies, Aged

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38802682
https://repository.publisso.de/resource/frl:6492491
https://epub.uni-regensburg.de/58341/

Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO

Autori: Zaher Alwafai Maximilian Heinz Beck Sepideh Fazeli a ďalší

Zdroj: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)

Predmety: Research, Carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Hysterectomy, Endometrial sampling, Endometrial Neoplasms, 3. Good health, Endometrium, Endometrial cancer, Diagnosis, Carcinoma, Endometrioid/pathology [MeSH], Endometrium/surgery [MeSH], Female [MeSH], Neoplasm Grading [MeSH], Endometrial Neoplasms/surgery [MeSH], Hysterectomy [MeSH], Accuracy, Humans [MeSH], Retrospective Studies [MeSH], Carcinoma/pathology [MeSH], Neoplasm Staging [MeSH], Endometrial Neoplasms/pathology [MeSH], Endometrium/pathology [MeSH], Endometrial Neoplasms/diagnosis [MeSH], Humans, Female, Neoplasm Grading, Carcinoma, Endometrioid, RC254-282, Retrospective Studies, Neoplasm Staging

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38528468
https://doaj.org/article/ea3b58d45be94fb78cb06293c3e03882
https://ruj.uj.edu.pl/handle/item/346198
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-024-12127-7
https://repository.publisso.de/resource/frl:6524252

Expression of estrogen-related receptors in ovarian cancer and impact on survival

Autori: Schüler-Toprak, Susanne Weber, Florian Skrzypczak, Maciej a ďalší

Zdroj: J Cancer Res Clin Oncol

Predmety: Ovarian Neoplasms, ERRalpha Estrogen-Related Receptor, ddc:610, 610 Medizin, Prognosis, Adenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Endometrial Neoplasms, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Receptors, Estrogen, Cystadenocarcinoma, Serous/pathology [MeSH], Ovarian Neoplasms/mortality [MeSH], Cystadenocarcinoma, Serous/metabolism [MeSH], Adenocarcinoma, Mucinous/mortality [MeSH], Endometrial Neoplasms/mortality [MeSH], Tissue microarray, Ovarian Neoplasms/metabolism [MeSH], Estrogen-related receptors, Adenocarcinoma, Clear Cell/metabolism [MeSH], Ovarian Neoplasms/pathology [MeSH], Adenocarcinoma, Mucinous/metabolism [MeSH], Female [MeSH], Endometrial Neoplasms/metabolism [MeSH], Follow-Up Studies [MeSH], Original Article – Cancer Research, Receptors, Estrogen/metabolism [MeSH], Ovarian cancer, Humans [MeSH], Overall survival, Retrospective Studies [MeSH], Cystadenocarcinoma, Serous/mortality [MeSH], Adenocarcinoma, Clear Cell/mortality [MeSH], Survival Rate [MeSH], Endometrial Neoplasms/pathology [MeSH], Adenocarcinoma, Clear Cell/pathology [MeSH], Biomarkers, Tumor/metabolism [MeSH], Adenocarcinoma, Mucinous/pathology [MeSH], Prognosis [MeSH], Progression-free survival, Estrogen-related receptors, Ovarian cancer, Overall survival, Progression-free survival, Tissue microarray, Biomarkers, Tumor, Humans, Female, Adenocarcinoma, Clear Cell, Follow-Up Studies, Retrospective Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00432-021-03673-9.pdf
https://pubmed.ncbi.nlm.nih.gov/34089362
https://link.springer.com/content/pdf/10.1007/s00432-021-03673-9.pdf
https://www.ncbi.nlm.nih.gov/pubmed/34089362
https://epub.uni-regensburg.de/45989/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310835
https://link.springer.com/article/10.1007/s00432-021-03673-9
https://pubmed.ncbi.nlm.nih.gov/34089362/
https://link.springer.com/article/10.1007/s00432-021-03673-9
https://doi.org/10.1007/s00432-021-03673-9
https://repository.publisso.de/resource/frl:6449854
https://epub.uni-regensburg.de/45989/

Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review

Autori: Huber, D. Seitz, S. Kast, K. a ďalší

Prispievatelia: Huber, D. Seitz, S. Kast, K. a ďalší

Zdroj: J Cancer Res Clin Oncol

Predmety: BRCA2 Protein, Ovarian Neoplasms, ddc:610, Heterozygote, Review – Clinical Oncology, BRCA1 Protein, Hormone Replacement Therapy, 610 Medizin, BRCA2 Protein/genetics [MeSH], Breast Neoplasms/etiology [MeSH], Genetic Predisposition to Disease [MeSH], Female [MeSH], Heterozygote [MeSH], Mutation [MeSH], Hormone Replacement Therapy/adverse effects [MeSH], Ovarian cancer, BRCA1 Protein/genetics [MeSH], Humans [MeSH], Breast cancer, Endometrial Neoplasms/etiology [MeSH], Hormone replacement therapy, Endometrial Neoplasms/pathology [MeSH], Ovarian Neoplasms/etiology [MeSH], Breast Neoplasms/pathology [MeSH], Ovarian Neoplasms/pathology [MeSH], Breast Neoplasms, Endometrial Neoplasms, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Hormone replacement therapy, Breast cancer, Ovarian cancer, BRCA1, BRCA2, Mutation, Humans, Female, Genetic Predisposition to Disease

Popis súboru: application/pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00432-021-03629-z.pdf
https://pubmed.ncbi.nlm.nih.gov/33885953
https://link.springer.com/article/10.1007/s00432-021-03629-z
https://epub.uni-regensburg.de/45586/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164576
https://europepmc.org/article/MED/33885953
https://www.ncbi.nlm.nih.gov/pubmed/33885953
https://pubmed.ncbi.nlm.nih.gov/33885953/
https://resolver.sub.uni-goettingen.de/purl?gro-2/123220
https://repository.publisso.de/resource/frl:6449882
https://epub.uni-regensburg.de/45586/

Fertility preserving management of early endometrial cancer in a patient cohort at the department of women’s health at the university of Tuebingen

Autori: Jürgen Andress Jana Pasternak Christina Walter a ďalší

Zdroj: Arch Gynecol Obstet

Predmety: Adult, Antineoplastic Agents, Hormonal, Fertility Preservation, Gynecologic Oncology, Conservative Treatment, Endometrial Neoplasms, 3. Good health, 03 medical and health sciences, Fertility, Treatment Outcome, 0302 clinical medicine, Pregnancy, Germany, Endometrial Hyperplasia, Humans, Female, Endometrial Neoplasms/drug therapy [MeSH], Female [MeSH], Adult [MeSH], Endometrial Hyperplasia/pathology [MeSH], Humans [MeSH], Endometrial Hyperplasia/drug therapy [MeSH], Treatment Outcome [MeSH], Fertility [MeSH], Retrospective Studies [MeSH], Fertility Preservation/methods [MeSH], Organ Sparing Treatments/methods [MeSH], Fertility sparing treatment, Endometrial Neoplasms/pathology [MeSH], Complex atypical hyperplasia, Progestins/therapeutic use [MeSH], Antineoplastic Agents, Hormonal/administration, Germany [MeSH], Low-grade endometrial cancer, Progestins/administration, Antineoplastic Agents, Hormonal/therapeutic use [MeSH], Progestin agents, Conservative Treatment [MeSH], Pregnancy [MeSH], Progestins, Organ Sparing Treatments, Retrospective Studies

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00404-020-05905-8.pdf
https://pubmed.ncbi.nlm.nih.gov/33606091
https://pubmed.ncbi.nlm.nih.gov/33606091/
http://europepmc.org/article/MED/33606091
https://www.ncbi.nlm.nih.gov/pubmed/33606091
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164611
https://link.springer.com/content/pdf/10.1007/s00404-020-05905-8.pdf
https://link.springer.com/article/10.1007/s00404-020-05905-8
https://repository.publisso.de/resource/frl:6450650

The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations

Autori: Wilko Weichert Katja Steiger Barbara Willvonseder a ďalší

Zdroj: Cancer Immunol Immunother

Predmety: Adult, Aged, 80 and over, 0301 basic medicine, Middle Aged, Prognosis, ddc, Endometrial Neoplasms, 3. Good health, Survival Rate, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Carcinoma, Endometrioid/pathology [MeSH], Carcinoma, Endometrioid/immunology [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Tumor Microenvironment/immunology [MeSH], Original Article, Endometrial Neoplasms/genetics [MeSH], Immunologic microenvironment, Female [MeSH], Follow-Up Studies [MeSH], Mutation [MeSH], Adult [MeSH], Humans [MeSH], Endometrial Neoplasms/immunology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Microsatellite Instability [MeSH], Lymphocytes, Tumor-Infiltrating/immunology [MeSH], Survival Rate [MeSH], Endometrial Neoplasms/pathology [MeSH], Carcinoma, Endometrioid/genetics [MeSH], Prognostic impact, Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], Molecular subgroups, Endometrioid endometrial cancer, Mutation, Biomarkers, Tumor, Tumor Microenvironment, Humans, Female, Microsatellite Instability, Carcinoma, Endometrioid, Aged, Follow-Up Studies, Retrospective Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00262-020-02813-3.pdf
https://pubmed.ncbi.nlm.nih.gov/33340331
https://www.ncbi.nlm.nih.gov/pubmed/33340331
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139910
https://www.scilit.net/article/83835c3a0e39e004b97e7df08f29b479?action=show-references
https://pubmed.ncbi.nlm.nih.gov/33340331/
https://link.springer.com/content/pdf/10.1007/s00262-020-02813-3.pdf
https://link.springer.com/article/10.1007/s00262-020-02813-3
https://repository.publisso.de/resource/frl:6470080
https://epub.ub.uni-muenchen.de/76399/
https://mediatum.ub.tum.de/doc/1624234/document.pdf

Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer

Autori: Beyer, Susanne Chen, Fangfang Meister, Sarah a ďalší

Zdroj: Histochem Cell Biol

Predmety: 0301 basic medicine, Original Paper, 0303 health sciences, Female [MeSH], Endometrial Neoplasms/metabolism [MeSH], Aged [MeSH], Humans [MeSH], Endometrial cancer, Survival Analysis [MeSH], Sirtuin1, HDAC, Immunohistochemistry [MeSH], Endometrial Neoplasms/pathology [MeSH], Sirtuin 1/biosynthesis [MeSH], Survival, Adenocarcinoma, Clear Cell/pathology [MeSH], Uterine Neoplasms/pathology [MeSH], Adenocarcinoma, Clear Cell/metabolism [MeSH], Uterine Neoplasms/metabolism [MeSH], Immunohistochemistry, Survival Analysis, Endometrial Neoplasms, 3. Good health, 03 medical and health sciences, Sirtuin 1, Uterine Neoplasms, Humans, Female, Adenocarcinoma, Clear Cell, Aged

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00418-020-01873-x.pdf
https://epub.ub.uni-muenchen.de/73081/1/Beyer2020_Article_Sirtuin1ExpressionAndSurvivalI.pdf
https://pubmed.ncbi.nlm.nih.gov/32388637
https://www.ncbi.nlm.nih.gov/pubmed/32388637
https://link.springer.com/article/10.1007/s00418-020-01873-x
https://pubmed.ncbi.nlm.nih.gov/32388637/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429549
https://link.springer.com/content/pdf/10.1007/s00418-020-01873-x.pdf
https://epub.ub.uni-muenchen.de/73081/
http://www.thieme-connect.de/products/ejournals/html/10.1055/s-0040-1717187
https://repository.publisso.de/resource/frl:6467542
https://epub.ub.uni-muenchen.de/73081/

Klinische Implikationen der PORTEC-3-Studie zur Behandlung des Hochrisikoendometriumkarzinoms

Autori: Waltar, Till Marnitz, Simone

Zdroj: Strahlentherapie und Onkologie. 196:410-413

Predmety: 03 medical and health sciences, 0302 clinical medicine, Chemoradiotherapy, Adjuvant [MeSH], Paclitaxel/administration, Female [MeSH], Area Under Curve [MeSH], Disease Progression [MeSH], Hysterectomy [MeSH], Cisplatin/administration, Brachytherapy [MeSH], Humans [MeSH], Literatur Kommentiert, Risk Factors [MeSH], Endometrial Neoplasms/mortality [MeSH], Oncology, Lymph Node Excision [MeSH], Neoplasm Staging [MeSH], Survival Rate [MeSH], Chemotherapy, Adjuvant [MeSH], Endometrial Neoplasms/pathology [MeSH], Neoplasm Recurrence, Local/radiotherapy [MeSH], Endometrial Neoplasms/radiotherapy [MeSH], Combined Modality Therapy [MeSH], Radiotherapy, Neoplasm Recurrence, Local/mortality [MeSH], 3. Good health

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00066-020-01592-1.pdf
https://pubmed.ncbi.nlm.nih.gov/32072198/
https://www.ncbi.nlm.nih.gov/pubmed/32072198
https://link.springer.com/content/pdf/10.1007%2Fs00066-020-01592-1.pdf
https://link.springer.com/article/10.1007/s00066-020-01592-1
https://paperity.org/p/233545483/klinische-implikationen-der-portec-3-studie-zur-behandlung-des
https://repository.publisso.de/resource/frl:6441856